Research > ETFs > ETF / ETP Commentary > 

VettaFi Acquires RAFI Indices: Bringing Institutional-Grade Research to Your Portfolio

  • Related Symbols
  • PRF
VettaFi today announced it has signed a definitive agreement to acquire RAFI Indices, the renowned pioneer in fundamental indexing, from Research Affiliates.VettaFi today announced it has signed a definitive agreement to acquire RAFI Indices, the renowned pioneer in fundamental indexing, from Research Affiliates. For two decades, RAFI Indices has been at the forefront of fundamental indexing, grounded in deep research and a commitment to helping investors achieve long-term success. Now, this acquisition unites RAFI’s world-class intellectual property with VettaFi’s cutting-edge index technology and expansive insights platforms. What does this mean for investors? Simply put, it means your portfolio gains direct access to decades of pioneering, academic-grade research. RAFI’s legacy was built on rigorous market analysis – focusing on the fundamental economic footprints of companies rather than just their stock prices. By bringing these two powerhouses together, VettaFi is expanding the reach of RAFI’s elite research engine. This ensures that the deep-dive market analysis and battle-tested insights that have historically driven the industry’s most respected smart beta strategies are more accessible than ever to empower your investments. In fact, you may already be investing in RAFI-powered strategies. Upon completion of the transaction, this milestone acquisition is expected to bring VettaFi’s combined asset base to more than $260 billion. RAFI Indices currently serve as the engines behind several of the market’s most popular smart beta exchange-traded funds (ETFs), including the $25 billion Schwab Fundamental U.S. Large Company Index ETF and the $10 billion Invesco RAFI 1000 ETF (PRF A-). “RAFI Indices has long set the gold standard for fundamental indexing,” said Tom Hendrickson, President of VettaFi. “By integrating RAFI’s deep, institutional-grade research with our modern technology infrastructure, we are uniquely positioned to deliver an even broader suite of innovative, data-driven investment solutions. We are excited to welcome the brilliant minds of the RAFI team into the VettaFi family as we continue to build what’s next in index ETFs – together.” “Today, we begin an exciting new chapter in the RAFI story. Our simple idea of creating an index strategy that selects and weights using fundamental measures of size, rather than price or market value, advanced the state of the art for equity investing,” said Rob Arnott, Founding Partner and Board Chair of Research Affiliates. “With TMX VettaFiʼs resources and our shared vision, they will be properly equipped to take RAFI and our newer strategies in cap-weighted core and growth investing to new levels of global success.” The transaction is expected to formally close in the coming weeks, subject to customary closing conditions. The full press release can be found here. For more news, information, and strategy, visit ETFdb.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.